The management of thrombosis in the antiphospholipid-antibody syndrome

New England Journal of Medicine

Volumn 332, Issue 15, 1995, Pages 993-997

  Khamashta, Munther A ^a   Cuadrado, Maria Jose ^a   Mujic, Fedza ^a   Taub, Nick A ^b   Hunt, Beverley J ^b   Hughes, Graham R v ^a  

^a Rayne Institute   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; DISEASE ASSOCIATION; DISEASE CONTROL; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; FOLLOW-UP STUDIES; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; RECURRENCE; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; THROMBOSIS; WARFARIN;

EID: 0028908094     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199504133321504     Document Type: Article

References (32)

1. Hughes GRV Thrombosis, abortion, cerebral disease and lupus anticoagulant. BMJ 1983; 287.: 1088-1089
2. Tan EM, Cohen AS, Fries JF, The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25.: 1271-1277
3. Asherson RA, Khamashta MA, Ordi-Ros J, The “primary” antiphospholipid syndrome.: major clinical and serological features. Medicine (Baltimore) 1989; 68.: 366-374
4. Mackworth-Young CG, Loizou S, Walport MJ Primary antiphospholipid syndrome.: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989; 48.: 362-367
5. Alarcon-Segovia D, Sanchez-Guerrero J Primary antiphospholipid syndrome. J Rheumatol 1989; 16.: 482-488 [Erratum, J Rheumatol 1989;16.:1014.]
6. Lie JT Vasculopathy in the antiphospholipid syndrome.: thrombosis or vasculitis, or both? J Rheumatol 1989; 16.: 713-715
7. Hughes GRV The antiphospholipid syndrome.: ten years on. Lancet 1993; 342.: 341-344
8. Lockshin MD Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993; 19.: 235-247
9. Levine SR, Brey RL, Joseph CLM, Havstad S Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 1992; 23.: Suppl I.: I-29
10. Rosove MH, Brewer PMC Antiphospholipid thrombosis.: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117.: 303-308
11. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993; 52.: 689-692
12. Asherson RA, Baguley E, Pal C, Hughes GRV Antiphospholipid syndrome.: five year follow up. Ann Rheum Dis 1991; 50.: 805-810
13. Rivier G, Herranz MT, Khamashta MA, Hughes GRV Thrombosis and antiphospholipid syndrome.: a preliminary assessment of three antithrombotic treatments. Lupus 1994; 3.: 85-90
14. Vlachoyiannopoulos PG, Tsiakou E, Chalevelakis G, Raptis SA, Moutsopoulos HM Antiphospholipid syndrome.: clinical and therapeutic aspects. Lupus 1994; 3.: 91-96
15. Harris EN, Baguley E, Asherson RA, Hughes GRV Clinical and serological features of the antiphospholipid syndrome (APS). Br J Rheumatol 1987; 26.: Suppl 2.: 19-19 abstract.
16. Special report from the National Institute of Neurological Disorders and Stroke.: classification of cerebrovascular diseases III. Stroke 1990; 21.: 637-676
17. Exner T, Rickard KA, Kronenberg H Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology 1975; 7.: 319-328
18. Lupus Anticoagulant Working PartyGuidelines on testing for the lupus anticoagulant. J Clin Pathol 1991; 44.: 885-889
19. Gharavi AE, Harris EN, Asherson RA, Hughes GRV Anticardiolipin antibodies.: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46.: 1-6
20. Harris EN, Gharavi AE, Patel SP, Hughes GRV Evaluation of the anti-cardiolipin antibody test.: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68.: 215-222
21. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford, England.: Blackwell Scientific, 1994.:144-6, 234-6.
22. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53.: 457-481
23. Cox DR Regression models and life-tables. J R Stat Soc [B] 1972; 34.: 187-202
24. Asherson RA, Chan JKH, Harris EN, Gharavi AE, Hughes GRV Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis 1985; 44.: 823-825
25. Vianna JL, Khamashta MA, Ordi-Ros J, Comparison of the primary and secondary antiphospholipid syndrome.: a European Multicenter Study of 114 patients. Am J Med 1994; 96.: 3-9
26. Barbui T, Finazzi G Clinical trials on antiphospholipid syndrome.: what is being done and what is needed? Lupus 1994; 3.: 303-307
27. Hull R, Hirsh J, Jay R, Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982; 307.: 1676-1681
28. Saour JN, Sieck JO, Mamo LAR, Gallus AS Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990; 322.: 428-432
29. Hirsh J, Fuster V Guide to anticoagulant therapy. Part 2. Oral anticoagulants. Circulation 1994; 89.: 1469-1480
30. Bern MM, Lokich JJ, Wallach SR, Very low doses of warfarin can prevent thrombosis in central venous catheters.: a randomized prospective trial. Ann Intern Med 1990; 112.: 423-428
31. Levine M, Hirsh J, Gent M, Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343.: 886-889
32. Poller L, McKernan A, Thomson JM, Elstein M, Hirsch PJ, Jones JB Fixed minidose warfarin.: a new approach to prophylaxis against venous thrombosis after major surgery. BMJ 1987; 295.: 1309-1312